INS and COVID-19: Due to the mostly qualitative and anecdotal nature of the current literature available examining DKA in COVID-19-positive patients, this study was designed to quantify intravenous (IV) regular human insulin (RHI) infusion requirements between DKA patients that were COVID-19 positive versus those that were COVID-19 negative.